25
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of potentially inappropriate prescriptions in primary care and correlates with mild cognitive impairment

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Potentially inappropriate prescribing is clearly associated with adverse health consequences among older people. Nevertheless, scarce evidence exists regarding the prevalence of potentially inappropriate prescriptions (PIP) in Albania, a Western Balkans country.

          Objective:

          The aim of this study was to assess the prevalence of PIP among older Albanian patients in primary care and to determine the associated sociodemographic and medical factors, including the presence of mild cognitive impairment (MCI).

          Methods:

          Cross-sectional study in two primary healthcare centers located in two different cities of Albania, a middle-income country in the Western Balkans. The Montreal Cognitive Assessment (MoCA) tool was applied to evaluate MCI. PIPs were assessed by two trained pharmacists using the Beers criteria 2019 update. Multivariate logistic regression analysis was conducted for possible risk factors predicting PIP in the study population.

          Results:

          At least one PIP was identified among 40.23 % of the participants (174 older patients) and 10.35 % had more than one PIP. MCI was detected among 79.31 % of the patients. The most commonly represented drug groups in PIP were diuretics (24.71 %), benzodiazepines in the presence of MCI and antidepressants (both 8.62 %). The lack of electrolytes monitoring was the most common reason for PIP. According to the multivariate analysis, the only statistically significant association observed was between PIP and number of drugs prescribed [three to four drugs (OR 3.34; 95% CI 1.65:6.76), five or more than five drugs (OR 4.08; 95% CI 1.42:11.69)].

          Conclusions:

          About four out of 10 older Albanian patients experience PIP in primary care. Further studies are needed for a comprehensive estimation of the prevalence and factors associated with PIP, particularly among elderly with mild cognitive impairment.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

          (2019)
          The American Geriatrics Society (AGS) Beers Criteria® (AGS Beers Criteria®) for Potentially Inappropriate Medication (PIM) Use in Older Adults are widely used by clinicians, educators, researchers, healthcare administrators, and regulators. Since 2011, the AGS has been the steward of the criteria and has produced updates on a 3-year cycle. The AGS Beers Criteria® is an explicit list of PIMs that are typically best avoided by older adults in most circumstances or under specific situations, such as in certain diseases or conditions. For the 2019 update, an interdisciplinary expert panel reviewed the evidence published since the last update (2015) to determine if new criteria should be added or if existing criteria should be removed or undergo changes to their recommendation, rationale, level of evidence, or strength of recommendation. J Am Geriatr Soc 67:674-694, 2019.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.

            Screening tests play a crucial role in dementia diagnostics, thus they should be very sensitive for mild cognitive impairment (MCI) assessment. Nowadays, the MiniMental State Examination (MMSE) is the most commonly used scale in cognitive function evaluation, albeit it is claimed to be imprecise for MCI detection. The Montreal Cognitive Assessment (MoCA), was created as an alternative method for MMSE. Aim. MoCA vs. MMSE credibility assessment in detecting MCI, while taking into consideration the sensitivity and specificity by cut-off points.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores.

              The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) is a cognitive screening tool that aims to differentiate healthy cognitive aging from Mild Cognitive Impairment (MCI). Several validation studies have been conducted on the MoCA, in a variety of clinical populations. Some studies have indicated that the originally suggested cutoff score of 26/30 leads to an inflated rate of false positives, particularly for those of older age and/or lower education. We conducted a systematic review and meta-analysis of the literature to determine the diagnostic accuracy of the MoCA for differentiating healthy cognitive aging from possible MCI.
                Bookmark

                Author and article information

                Contributors
                Journal
                Pharm Pract (Granada)
                Pharm Pract (Granada)
                Pharmacy Practice
                Centro de Investigaciones y Publicaciones Farmaceuticas
                1885-642X
                1886-3655
                Jul-Sep 2020
                22 August 2020
                : 18
                : 3
                : 2017
                Affiliations
                PhD. Department of Pharmacy, Faculty of Medicine, University of Medicine of Tirana . Tirana (Albania). klejda.harasani@ 123456umed.edu.al
                PhD. Department of Pharmacy, Faculty of Medicine, University of Medicine of Tirana . Tirana (Albania). delinahudhra@ 123456gmail.com
                MSc. Department of Pharmacy, Faculty of Medicine, University of Medicine of Tirana . Tirana (Albania). anxhelabegolli@ 123456hotmail.com
                PhD. Public Foundation for Biomedical Research of Oriental Andalusia . Granada (Spain). manme_olv@ 123456hotmail.com
                Author information
                https://orcid.org/0000-0002-1877-6662
                https://orcid.org/0000-0002-9166-8270
                https://orcid.org/0000-0001-9786-4443
                https://orcid.org/0000-0002-8374-064X
                Article
                pharmpract-18-2017
                10.18549/PharmPract.2020.3.2017
                7470240
                32922574
                ba1c36fd-dcb4-4894-9c20-966c9872ea4b
                Copyright: © Pharmacy Practice and the Authors

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 08 June 2020
                : 16 August 2020
                Categories
                Original Research

                inappropriate prescribing,potentially inappropriate medication list,cognitive dysfunction,antidepressive agents,benzodiazepines,aged,risk factors,pharmacists,cross-sectional studies,multivariate analysis,albania

                Comments

                Comment on this article

                scite_

                Similar content120

                Cited by3

                Most referenced authors252